Literature DB >> 2168021

Antagonism of the effects of 5-hydroxytryptamine on the rabbit isolated vagus nerve by BRL 43694 and metoclopramide.

P Elliott1, B M Seemungal, D I Wallis.   

Abstract

Depolarization and reduction in the C fibre compound action potential (C spike) in response to 5-HT were recorded simultaneously from rabbit isolated vagus nerve. 5-HT (0.1-100 mumol/l) was applied cumulatively and EC50 and IC50 values measured from individual concentration-response curves. Blockade of 5-HT responses by the 3-indazole carboxamide, BRL 43694, was investigated and compared with the blocking action of metoclopramide. BRL 43694 was a selective antagonist of 5-HT responses. A concentration of 10 nmol/l BRL 43694, which nearly abolished the depolarization and reduction of the C spike evoked by 5-HT (100 mumol/l), had no effect on similar responses evoked by DMPP (100 mumol/l) or GABA (100 mumol/l). Blockade of 5-HT responses by BRL 43694 (0.3 nmol/l) was slow in onset, a plateau blockade occurring after equilibrium of tissue with antagonist for 2 to 3 h. Metoclopramide induced a blockade of rapid onset. The maximal blockade was apparent within 30 min of application. Full recovery in the responsiveness of the tissue to 5-HT was observed within 30 min of washing out metoclopramide. BRL 43694 at concentrations of 0.3, 1, 3 and 10 nmol/l caused a progressive rightward shift of the concentration-response curves to 5-HT. At the highest concentration of antagonist, there was some depression of the maximal 5-HT response. The apparent pA2 estimated from the Schild equation was 10.03 +/- 0.09 (mean +/- SEM, n = 20) against 5-HT depolarization and 10.31 +/- 0.1 against C spike reduction. Schild plots had slopes not significantly different from 1.0.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2168021     DOI: 10.1007/BF00171729

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  14 in total

1.  Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors.

Authors:  A Butler; J M Hill; S J Ireland; C C Jordan; M B Tyers
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

2.  Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding.

Authors:  G J Kilpatrick; B J Jones; M B Tyers
Journal:  Nature       Date:  1987 Dec 24-31       Impact factor: 49.962

3.  Pharmacological characterization of serotonin 5-HT3 receptor-mediated electrical response in cultured mouse neuroblastoma cells.

Authors:  H C Neijt; I J te Duits; H P Vijverberg
Journal:  Neuropharmacology       Date:  1988-03       Impact factor: 5.250

4.  Further studies on the blockade of 5-HT depolarizations of rabbit vagal afferent and sympathetic ganglion cells by MDL 72222 and other antagonists.

Authors:  A Round; D I Wallis
Journal:  Neuropharmacology       Date:  1987-01       Impact factor: 5.250

5.  One the importance of agonist concentration-gradients within isolated tissues. Increased maximal responses of rat vasa deferentia to (--)-noradrenaline after blockade of neuronal uptake.

Authors:  T P Kenakin
Journal:  J Pharm Pharmacol       Date:  1980-12       Impact factor: 3.765

6.  Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs.

Authors:  B P Richardson; G Engel; P Donatsch; P A Stadler
Journal:  Nature       Date:  1985 Jul 11-17       Impact factor: 49.962

7.  Analysis of the actions of 5-hydroxytryptamine on the rabbit isolated vagus nerve.

Authors:  P Elliott; D I Wallis
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

8.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

9.  Pharmacological characterization of 5-hydroxytryptamine-induced depolarization of the rat isolated vagus nerve.

Authors:  S J Ireland; M B Tyers
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

10.  The depolarizing action of 5-hydroxytryptamine on rabbit vagal primary afferent and sympathetic neurones and its selective blockade by MDL 72222.

Authors:  J Azami; J R Fozard; A A Round; D I Wallis
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-02       Impact factor: 3.000

View more
  9 in total

Review 1.  Granisetron. A review of its pharmacological properties and therapeutic use as an antiemetic.

Authors:  G L Plosker; K L Goa
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

Review 2.  Ondansetron: a pharmacoeconomic and quality-of-life evaluation of its antiemetic activity in patients receiving cancer chemotherapy.

Authors:  G L Plosker; R J Milne
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

3.  Analysis of the actions of 5-hydroxytryptamine on the rabbit isolated vagus nerve.

Authors:  P Elliott; D I Wallis
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

4.  Identification of metoclopramide metabolites in the urine of cattle by gas chromatography-mass spectrometry and high-performance liquid chromatography-photodiode array detection.

Authors:  R D Jones; C D Blanton; J M Bowen
Journal:  Vet Res Commun       Date:  1993       Impact factor: 2.459

5.  Possible cardiac side effects of granisetron, an antiemetic agent, in patients with bone and soft-tissue sarcomas receiving cytotoxic chemotherapy.

Authors:  H Watanabe; A Hasegawa; T Shinozaki; S Arita; M Chigira
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

Review 6.  Volunteer models for predicting antiemetic activity of 5-HT3-receptor antagonists.

Authors:  N A Minton
Journal:  Br J Clin Pharmacol       Date:  1994-06       Impact factor: 4.335

Review 7.  Granisetron. An update of its therapeutic use in nausea and vomiting induced by antineoplastic therapy.

Authors:  Y E Yarker; D McTavish
Journal:  Drugs       Date:  1994-11       Impact factor: 9.546

8.  Preoperative Use of 10-mg Metoclopramide and 50-mg Dimenhydrinate in the Prophylaxis of Postoperative Nausea and Vomiting in Elective Caesarean Births: A Prospective Randomized Clinical Study.

Authors:  Ürfettin Hüseyinoğlu; Kahraman Ülker
Journal:  J Obstet Gynaecol India       Date:  2015-05-09

9.  A comparative study between palonosetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy.

Authors:  Dhurjoti Prosad Bhattacharjee; Satrajit Dawn; Sushil Nayak; Pramod Ranjan Roy; Amita Acharya; Ramkrishna Dey
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2010-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.